Medicare Enrolled
Dr. Peter Farrugia, M.D.
Cardiovascular Disease · Colts Neck, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Farrugia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Farrugia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Farrugia
Dr. Peter Farrugia is a cardiovascular disease specialist in Colts Neck, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Farrugia performed 3,769 Medicare services across 1,114 unique beneficiaries.
Between the years covered by Open Payments, Dr. Farrugia received a total of $587,991 from 43 pharmaceutical and/or device companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Farrugia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 29% volume in NJ
$587,991 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,769
Medicare services
Top 29% in NJ for cardiovascular disease
1,114
Unique beneficiaries
$225
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~236 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,082 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
384 | $99 | $245 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
161 | $12 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
133 | $146 | $330 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
98 | $157 | $550 |
| Additional blood vessel ultrasound evaluation An ultrasound exam of a blood vessel that includes a radiologist's review. This code applies to each additional vessel evaluated beyond the initial one. |
87 | $149 | $400 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
75 | $130 | $375 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
74 | $34 | $50 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
74 | $57 | $210 |
| Ultrasound of blood vessel, initial vessel An ultrasound exam of a blood vessel that includes a radiologist's review of the initial vessel. |
73 | $850 | $2,500 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
69 | $210 | $610 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
62 | $77 | $170 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
61 | $129 | $260 |
| Arterial plaque removal, initial vessel A procedure to remove plaque buildup from an artery in the leg. This is performed on the first vessel treated during the session. |
52 | $7,061 | $27,500 |
| Arterial plaque removal in leg A procedure to remove plaque buildup from the arteries in the leg to restore blood flow. |
47 | $4,262 | $27,400 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
44 | $47 | $60 |
| Secondary removal and dissolving of blood clot from artery or artery graft using fluoroscopic guidance This procedure involves removing and dissolving a blood clot from an artery or artery graft. Fluoroscopic guidance is used to assist in the process. |
43 | $1,052 | $3,445 |
| New patient office visit, complex (60-74 min) | 36 | $167 | $465 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
20 | $146 | $465 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
19 | $157 | $200 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
18 | $387 | $1,135 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
18 | $165 | $475 |
| Arterial catheter insertion, initial third order branch Insertion of a tube into an abdominal, pelvic, or leg artery, specifically targeting the initial third order branch. |
14 | $1,216 | $3,635 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
13 | $61 | $160 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
12 | $10 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.0% high complexity
68.7% medium
28.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$587,991
Total received (2018-2024)
Avg $83,999/year across 7 years
Top 0% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
560
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$543,035 (92.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$36,189 (6.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,767 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$169,596
2023
$203,632
2022
$23,028
2021
$113,654
2020
$61,686
2019
$7,066
2018
$9,328
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Inari Medical, Inc.
$155,750
Bard Peripheral Vascular, Inc.
$13,542
Abbott Laboratories
$114
Becton, Dickinson and Company
$104
Philips North America LLC
$49
Medtronic, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$15
Top 3 companies account for 99.9% of 2024 payments
All-time payments by company (2018-2024) ›
Inari Medical, Inc.
$460,961
Bard Peripheral Vascular, Inc.
$72,826
Abbott Laboratories
$22,560
Cardiovascular Systems Inc.
$19,254
ARALEZ PHARMACEUTICALS US INC.
$2,656
Esperion Therapeutics, Inc.
$2,524
Penumbra, Inc.
$2,400
Janssen Pharmaceuticals, Inc
$941
Medtronic Vascular, Inc.
$883
AstraZeneca Pharmaceuticals LP
$309
BOSTON SCIENTIFIC CORPORATION
$272
Boston Scientific Corporation
$262
Philips Electronics North America Corporation
$250
iRhythm Technologies, Inc.
$221
Astellas Pharma US Inc
$212
Amgen Inc.
$167
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$129
ABIOMED
$120
Novartis Pharmaceuticals Corporation
$117
Becton, Dickinson and Company
$104
Acist Medical Systems, Inc.
$94
Cardinal Health 200, LLC
$81
Amarin Pharma Inc.
$70
Tryton Medical, Inc.
$66
Philips North America LLC
$49
E.R. Squibb & Sons, L.L.C.
$46
Kowa Pharmaceuticals America, Inc.
$42
SANOFI-AVENTIS U.S. LLC
$39
PFIZER INC.
$37
CVRx, Inc.
$36
Cardinal Health 200 LLC
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Regeneron Healthcare Solutions, Inc.
$27
AngioDynamics, Inc.
$26
Avinger Inc.
$25
Medtronic, Inc.
$22
CORDIS US CORP.
$21
C. R. Bard, Inc. & Subsidiaries
$20
Kiniksa Pharmaceuticals International, plc
$15
PORTOLA PHARMACEUTICALS, INC.
$15
Kiniksa Pharmaceuticals, Ltd.
$14
Allergan Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 94.6% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Extended Holter · (6578) Visions 018 · ABSOLUTE PRO · AMPLATZER · AMPLATZER Occluders · ANDEXXA · AURYON LASER SYSTEM 100-120 VAC · Absolute Pro vascular stent system · Absorb · Advisa · Arcalyst · Asahi Fielder coronary guide wire · Azure · BRILINTA · BYSTOLIC · Barostim Neo System · Bidil · CT THROMBECTOMY SYSTEM KIT · Corlanor · Coronary Orbital Atherectomy System · Crosser iQ · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · ELIQUIS · EMBOSHIELD NAV6 · ENTRESTO · EkoSonic · Emboshield NAV6 system · Endurant · FARXIGA · FEMOSTOP · FLOWTRIEVER CATHETER · FlowTriever · Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter · GENERAL ATHERECTOMY · GENERAL METALLIC STENTS · GENERAL VASCULAR INTERVENTION · GENERAL HYPERTENSION · GENERAL METALLIC STENTS · HawkOne · Hi-Torque Command guide wire · IN.PACT Admiral · Impella · Indigo · JARDIANCE · JETSTREAM · LEXISCAN · LOKELMA · LUTONIX · LUTONIX Drug Coated Balloon · LifeStent Solo Vascular Stent · LifeVest · Livalo · Lutonix Drug Coated Balloon · MYNX CONTROL · MYNX CONTROLTM · MynxGrip Vascular Closure Device · NEXLIZET · Omnilink Elite vascular stent system · PANTHERIS · PERCLOSE PROGLIDE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Perclose ProStyle · Peripheral Orbital Atherectomy System · RF CONTACTR · RXi Consumables · Repatha · Resolute · Rotarex · RotarexS 6 F x 135 cm · S · SUPERA · Supera peripheral stent system · Trilogy 100 · Tryton Side Branch Stent · Vascepa · Venclose Maven Catheter · Venovo · WATCHMAN · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent · ZIO Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for cardiovascular disease in NJ.
Geographic Context
Cardiologists within 10 mi
311
Per 100K population
48.3
County median income
$122,727
Nearest hospital
BAYSHORE MEDICAL CENTER
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Farrugia is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NJ), with consulting-driven industry engagement in the top 0% of NJ peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Farrugia experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Farrugia performed 2,082 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Farrugia receive payments from pharmaceutical companies?
Yes. Dr. Farrugia received a total of $587,991 from 43 companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Farrugia's costs compare to other cardiologists in Colts Neck?
Dr. Farrugia's average Medicare payment per service is $225. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Farrugia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Colts Neck
Browse cardiologists in Colts Neck ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Inari Medical, Inc. Payments to Doctors
See all physicians who received payments from Inari Medical, Inc.
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology